Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | IMGO | Common Stock | Disposition pursuant to a tender of shares in a change of control transaction | -$30.6K | -850 | -100% | $36.00 | 0 | Jan 11, 2023 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | IMGO | Stock Option (Right to Buy) | Disposed to Issuer | -114K | -100% | 0 | Jan 11, 2023 | Common Stock | 114K | $1.68 | Direct | F1 | ||
transaction | IMGO | Stock Option (Right to Buy) | Disposed to Issuer | -23.8K | -100% | 0 | Jan 11, 2023 | Common Stock | 23.8K | $16.00 | Direct | F1 | ||
transaction | IMGO | Stock Option (Right to Buy) | Disposed to Issuer | -11.9K | -100% | 0 | Jan 11, 2023 | Common Stock | 11.9K | $15.65 | Direct | F1 |
Robert Baltera is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.
Id | Content |
---|---|
F1 | On November 19, 2022, the Issuer entered into an Agreement and Plan of Merger (the "Merger Agreement"), by and among the Issuer, Merck Sharpe & Dohme LLC and M-Inspire Merger Sub, Inc., providing for the merger of M-Inspire Merger Sub, Inc. with and into the Issuer (the "Merger"), with the Issuer surviving as a wholly owned subsidiary of Merck Sharpe & Dohme LLC. Pursuant to the Merger Agreement, each option to purchase common stock of the Issuer, whether vested or unvested, outstanding immeditately prior to the effective time of the Merger, were exchanged for a cash payment equal to (x) the aggregate number of shares of the Issuer's common stock subject to such option, multiplied by (y) the excess, if any, of $36.00 over the per share exercise price under such option. |